Kurokawa, C., Iankov, I. D., Aderca, I., Galanis, E., Anderson, S. K., Leontovich, A. A., . . . Parney, I. F. (2018). Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy. JNCI: Journal of the National Cancer Institute, 110(10), 1123-1133.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Kurokawa, Cheyne, et al. "Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy."
JNCI: Journal of the National Cancer Institute 110, no. 10 (2018): 1123-1133.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Kurokawa, Cheyne, et al. "Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy."
JNCI: Journal of the National Cancer Institute, vol. 110, no. 10, 2018, pp. 1123-1133.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.